In Alzheimer’s disease (AD), a potential therapeutic strategy could be achieved through the upregulation of parkin-mediated mitophagy by overexpressing parkin to improve impaired mitochondria [76]. The gene discussed is PRKN; the disease is Alzheimer disease.